Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil.
作者信息
Siqueira Priscila C, Cola João P, Comerio Tatiane, Sales Carolina M M, Maciel Ethel L
机构信息
. Programa de Pós Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Vitória (ES), Brasil.
. Laboratório de Epidemiologia, Universidade Federal do Espirito Santo, Vitória (ES), Brasil.
出版信息
J Bras Pneumol. 2022 May 30;48(2):e20210401. doi: 10.36416/1806-3756/e20210401.
Abstract
摘要
相似文献
1
Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil.
J Bras Pneumol. 2022 May 30;48(2):e20210401. doi: 10.36416/1806-3756/e20210401.
2
Vaccination Is the Only Acceptable Path to Herd Immunity.
Med. 2020 Dec 18;1(1):21-23. doi: 10.1016/j.medj.2020.12.004.
3
Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But Plausibile.
Infect Disord Drug Targets. 2022;22(4):e170122200309. doi: 10.2174/1871526522666220117153838.
4
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.
Euro Surveill. 2021 May;26(20). doi: 10.2807/1560-7917.ES.2021.26.20.2100428.
5
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
6
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
7
Brazil's COVID-19 Epicenter in Manaus: How Much of the Population Has Already Been Exposed and Are Vulnerable to SARS-CoV-2?
J Racial Ethn Health Disparities. 2022 Dec;9(6):2098-2104. doi: 10.1007/s40615-021-01148-8. Epub 2021 Sep 29.
8
Health experts welcome Brazil COVID-19 inquiry findings.
Lancet. 2021 Nov 6;398(10312):1674-1675. doi: 10.1016/S0140-6736(21)02398-9.
9
Herd immunity by infection is not an option.
Science. 2021 Jan 15;371(6526):230-231. doi: 10.1126/science.abf7921.
10
Lack of Convincing Evidence That the Widely Used COVID-19 Vaccines Will Produce Herd Immunity.
Am J Med. 2022 Aug;135(8):e231-e233. doi: 10.1016/j.amjmed.2022.01.037. Epub 2022 Feb 6.
引用本文的文献
1
How Does Vaccine-Induced Immunity Compare to Infection-Acquired Immunity in the Dynamics of COVID-19?
Pathogens. 2025 Feb 11;14(2):179. doi: 10.3390/pathogens14020179.
2
Achieving herd immunity in South America.
Glob Health Res Policy. 2023 Feb 1;8(1):2. doi: 10.1186/s41256-023-00286-2.
3
Are we near the end of the pandemic?
Rev Soc Bras Med Trop. 2022 May 20;55:e02332022. doi: 10.1590/0037-8682-0233-2022. eCollection 2022.
本文引用的文献
1
Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study.
Lancet Reg Health Am. 2022 Feb;6:100154. doi: 10.1016/j.lana.2021.100154. Epub 2021 Dec 22.
2
Infectious disease scenarios in a post-vaccine view of COVID-19 and future pandemics.
J Bras Pneumol. 2021 Dec 15;47(6):e20210314. doi: 10.36416/1806-3756/e20210314.
3
Lifting of COVID-19 restrictions in the UK and the Delta variant.
Lancet Respir Med. 2021 Aug;9(8):e85. doi: 10.1016/S2213-2600(21)00328-3. Epub 2021 Jul 12.
4
SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic.
Vet Q. 2021 Jan 1;41(1):50-60. doi: 10.1080/01652176.2020.1867776.
5
"Herd immunity": a rough guide.
Clin Infect Dis. 2011 Apr 1;52(7):911-6. doi: 10.1093/cid/cir007.
6
[Smallpox, an old foe].
Cad Saude Publica. 2001 Nov-Dec;17(6):1525-30. doi: 10.1590/s0102-311x2001000600024.
Zotero 插件